Møller, Maria Elizabeth Engel
Early Stimulated Immune Responses Predict Clinical Disease Severity in Hospitalized COVID-19 Patients
Svanberg, Rebecka
, MacPherson, Cameron
, Zucco, Adrian
, Agius, Rudi
, Faitova, Tereza
, Andersen, Michael Asger
, Da Cunha-Bang, Caspar
, Gjærde, Lars Klingen
, Møller, Maria Elizabeth Engel
, Brooks, Patrick Terrence
, Lindegaard, Birgitte
, Sejdic, Adin
, Gang, Anne Ortved
, Hersby, Ditte Stampe
, Brieghel, Christian
, Nielsen, Susanne Dam
, Podlekareva, Daria
, Hald, Annemette
, Bay, Jakob Thaning
, Marquart, Hanne
, Lundgren, Jens
, Lebech, Anne-Mette
, Helleberg, Marie
, Niemann, Carsten Utoft
, Ostrowski, Sisse Rye
Innate Immunity
Viral Infection
The immune pathogenesis underlying the diverse clinical course of COVID-19 is poorly understood. Currently, there is an unmet need in daily clinical practice for early biomarkers and improved risk stratification tools to help identify and monitor COVID-19 patients at risk of severe disease.